Prognostic value of pupil area for all-cause mortality in patients with heart failure.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
10 2020
Historique:
received: 21 02 2020
revised: 06 07 2020
accepted: 16 07 2020
pubmed: 11 8 2020
medline: 22 6 2021
entrez: 11 8 2020
Statut: ppublish

Résumé

The area of the pupil can be used as an indicator of autonomic function. However, the relation between pupil area and prognosis in heart failure (HF) patients remains unclear. This study was performed to examine whether pupil area can be used as a prognostic indicator in patients with HF. This retrospective review was performed in 870 consecutive patients (mean age: 67.0 ± 14.1 years, 37.0% women) hospitalized for acute HF. Pupil area was measured with a pupilometer at least 7 days after hospitalization for HF. The primary endpoint was all-cause mortality, and the secondary endpoint was readmission due to HF. A total of 131 patients died, and 328 patients were readmitted because of HF over a median follow-up of 1.9 (interquartile range: 1.0-3.7 years) years. After adjustment for several pre-existing prognostic factors, including Seattle Heart Failure Score (SHFS), pupil area was shown to be independently associated with all-cause mortality (hazard ratio: 0.72; 95% confidence interval: 0.59-0.88; P = 0.001) and readmission due to HF (hazard ratio: 0.82; 95% confidence interval: 0.73-0.93; P = 0.003). Addition of pupil area to SHFS significantly increased the area under the receiver-operating characteristic curve for all-cause mortality (0.69 vs. 0.72, respectively; P = 0.034). Pupil area is an independent predictor of all-cause mortality and readmission due to HF and adds prognostic information to SHFS in patients with HF. The results presented here suggest that pupil area may be useful as a prognostic marker in patients with HF.

Identifiants

pubmed: 32777862
doi: 10.1002/ehf2.12933
pmc: PMC7524244
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3067-3074

Subventions

Organisme : Japan Society for the Promotion of Science
ID : JP 19K19884
Pays : International

Informations de copyright

© 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.

Références

Diabetes Res Clin Pract. 1994 Nov;26(1):61-6
pubmed: 7875051
Int J Psychophysiol. 2003 Feb;47(2):95-115
pubmed: 12568941
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Clin Cardiol. 1996 Jun;19(6):503-8
pubmed: 8790957
J Am Coll Cardiol. 1992 Jul;20(1):248-54
pubmed: 1351488
Circulation. 2001 Oct 30;104(18):2200-4
pubmed: 11684631
J Card Fail. 2019 Jul;25(7):561-567
pubmed: 30099192
J Am Coll Cardiol. 2013 May 7;61(18):1935-44
pubmed: 23558044
Circulation. 2004 Oct 19;110(16):2389-94
pubmed: 15313946
ESC Heart Fail. 2020 Oct;7(5):3067-3074
pubmed: 32777862
N Engl J Med. 1971 Dec 23;285(26):1441-6
pubmed: 5122894
Clin Auton Res. 1992 Oct;2(5):335-41
pubmed: 1422101
Cranio. 2014 Apr;32(2):139-47
pubmed: 24839725
Circulation. 2011 Mar 8;123(9):1010-20
pubmed: 21382903
Eur J Heart Fail. 2012 Dec;14(12):1410-9
pubmed: 22851700
Circulation. 1998 Oct 13;98(15):1510-6
pubmed: 9769304
J Neurol Neurosurg Psychiatry. 1984 Jan;47(1):61-4
pubmed: 6319614
Clin Exp Rheumatol. 2006 Nov-Dec;24(6):683-9
pubmed: 17207385
Clin Exp Nephrol. 2009 Jun;13(3):191-248
pubmed: 19585186
Am Heart J. 2005 Feb;149(2):209-16
pubmed: 15846257
Diabetes Care. 2001 Jun;24(6):1093-8
pubmed: 11375376
Circ Heart Fail. 2018 Aug;11(8):e004969
pubmed: 30354566
Circulation. 2009 Jan 27;119(3):480-6
pubmed: 19171871
Cardiovasc Res. 2006 Jun 1;70(3):434-45
pubmed: 16480965
Circ J. 2009 Nov;73(11):2084-90
pubmed: 19755750
Int J Cardiol. 2016 Jan 1;202:21-6
pubmed: 26386914
Circulation. 2006 Mar 21;113(11):1424-33
pubmed: 16534009
J Am Coll Cardiol. 2008 May 6;51(18):1725-33
pubmed: 18452777
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
J Am Coll Cardiol. 1991 Aug;18(2):464-72
pubmed: 1856414
J Card Fail. 2019 Mar;25(3):156-163
pubmed: 30244182

Auteurs

Kohei Nozaki (K)

Department of Rehabilitation, Kitasato University Hospital, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0375, Japan.

Nobuaki Hamazaki (N)

Department of Rehabilitation, Kitasato University Hospital, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0375, Japan.

Shohei Yamamoto (S)

Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.

Kentaro Kamiya (K)

Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.
Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.

Shinya Tanaka (S)

Department of Rehabilitation, Nagoya University Hospital, Nagoya, Japan.

Takafumi Ichikawa (T)

Department of Rehabilitation, Kitasato University Hospital, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0375, Japan.

Takeshi Nakamura (T)

Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.

Masashi Yamashita (M)

Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.

Emi Maekawa (E)

Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.

Atsuhiko Matsunaga (A)

Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.
Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.

Minako Yamaoka-Tojo (M)

Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.
Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.

Junya Ako (J)

Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH